Results

Total Results: 1,430 records

Showing results for "continued".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/primary-healthcare-spending-disposition-comments.pdf
    May 17, 2024 - Disposition of Comments_Technical Brief No. 44: Measuring Primary Healthcare Spending Technical Brief Disposition of Comments Report Title: Measuring Primary Healthcare Spending Draft report available for public comment from September 29, 2023, to October 27, 2023. Citation: Cohen DJ, Totten…
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
    January 01, 2010 - Effective Health Care Topic Number: 0298 Document Completion Date: 03-19-12 1 Results of Topic Selection Process & Next Steps  Perinatal depression treatment will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparators, and ou…
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
    January 01, 2010 - 1 Comparative Effectiveness Review Number 57 Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is defined as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion from the pancreati…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
    October 12, 2016 - Global Organization for EPA and DHA Omega-35 Methodological Issues - Study Identification [continued … Rice, PhD VP, Reg. & Scientific Affairs Global Organization for EPA and DHA Omega-35 (continued … ) Evaluation of the Totality of Evidence (continued) 6 Makrides M1, Duley L, Olsen SF Marine oil … Rice, PhD VP, Reg. & Scientific Affairs Global Organization for EPA and DHA Omega-35 (continued … ) Evaluation of the Totality of Evidence (continued) 8 Szajewska H, Horvath A, Koletzko B.
  5. UBIQUS Document (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/oct_13_webinar_transript_10-13-11.pdf
    October 13, 2011 - Project Lead, and my own company SRA International have dedicated staff to identify and maintain continued … Like the Alamo supported continued education. And so ProjectLEAD is done [phonetic].
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
    January 01, 2022 - Executive Summary_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base Systematic Review Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidenc…
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - Among drug-eluting stent patients who were event-free at twelve months, clopidogrel use continued to … 0.0% with vs. 4.5% without, p<0.001) at 24 months; however, among bare metal stent patients there continued … Our study, therefore, provides new evidence that continued clopidogrel therapy conveys an important
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
    April 28, 2010 - Continued alcohol use despite having persistent or recurrent social or interpersonal problems caused … Markedly diminished effect with continued use of the same amount of alcohol 2. … Alcohol use is continued despite knowledge of having a persistent or recurrent physical or psychological … problem that is likely to have been caused or exacerbated by alcohol (e.g., continued drinking despite … behavioral interventions compared with controls for adults: Health, utilization, and other outcomes (continued
  9. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
    March 01, 2012 - GLP-1 also promotes a feeling of fullness and satiety to reduce continued intake of exogenous glucose … treatment period comparing the drug (20 or 40 mcg/day 0 with twice-daily exenatide injections, treatment continued … Eighty-five percent of enrolled patients continued and the company reported in September 2011 that
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-executive-summary.pdf
    December 01, 2024 - Continued on page 2 2 Background and Purpose OCD is a common
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
    May 31, 2025 - consolidation from multiple platforms to a single one Barriers in preparing for implementation Silos: 1) Continued
  12. Siminoff_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
    January 01, 2012 - college Slide 12: Seeking  a Diagnosis: Colorectal Cancer (4 of 4) Patient Characteristics  (Continued
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
    January 01, 2016 - Overview of Clinical Research Evidence (Continued) Factors Contributing to the Effectiveness of Behavioral
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
    January 01, 2020 - Summary of the strength of evidence from comparative effectiveness review (continued) Population BMI … We continued to use the Delphi process with our same stakeholders to prioritize questions for future … Questions from Comparative Effectiveness Review “Strategies To Prevent Weight Gain Among Adults” (continued … Questions from Comparative Effectiveness Review “Strategies To Prevent Weight Gain Among Adults” (continued … Questions from Comparative Effectiveness Review “Strategies To Prevent Weight Gain Among Adults” (continued
  15. effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
    January 03, 2012 - 145 Abstract This chapter provides an overview of study design and analytic assumptions made in observational comparative effectiveness research (CER), discusses assumptions that can be varied in a sensitivity analysis, and describes ways to implement a sensitivity analysis. All statistical models (and study result…
  16. effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
    March 01, 2021 - (continued on page 2) 2 Background and Purpose The purpose of this review is to assess the comparative
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
    November 01, 2020 - (continued on page 2) 2 Background and Purpose Primary headaches (i.e., conditions in which the
  18. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - ARBs for essential hypertension (continued) Strength of Key question evidence Conclusions 2.
  19. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
    January 01, 2023 - Healthcare-Related EPC Evidence Reports Posted in 2023 (continued) 14. … Manuscripts and Other Publications Derived From Healthcare-Related EPC Evidence Reports Published in 2023 (continued … Healthcare-Related EPC Evidence Reports in Progress in 2023 (continued) 26.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - Summary of evidence for Key Question 5: Benefits of treatment for patients with CKD stages 1–3 (continued … Summary of evidence for Key Question 5: Benefits of treatment for patients with CKD stages 1–3 (continued … Summary of evidence for Key Question 5: Benefits of treatment for patients with CKD stages 1–3 (continued … Summary of evidence for Key Question 5: Benefits of treatment for patients with CKD stages 1–3 (continued

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: